The landscape of diabetes care is advancing with the introduction of skin-applied GLP-1 therapy. These convenient delivery systems offer a likely simpler alternative to needle administrations for individuals living with type 2 diabetes . These patches deliver glucagon-like peptide-1 directly through the skin , avoiding the need for regular injectio